SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-23-000020
Filing Date
2023-03-01
Accepted
2023-03-01 06:43:12
Documents
14
Period of Report
2023-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K isee-20230301.htm   iXBRL 8-K 35328
2 EX-99.1 exhibit991-earnings4q2022p.htm EX-99.1 77378
6 image_0a.jpg GRAPHIC 38354
  Complete submission text file 0001410939-23-000020.txt   312018

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20230301.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20230301_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20230301_pre.xml EX-101.PRE 12525
8 EXTRACTED XBRL INSTANCE DOCUMENT isee-20230301_htm.xml XML 10555
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 23689641
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences